Navigation Links
Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
Date:12/29/2012

New York, New York (PRWEB) December 29, 2012

Pradaxa lawsuits continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to the court’s calendar, the next Status Conference in the litigation is scheduled for January 14, 2013 at 3:00 p.m. According to Case Management Order Number 11, Judge David Herndon has scheduled the Pradaxa litigation’s first trial for August 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are pleased to see this litigation moving ahead so expeditiously, and look forward to the Status Conference next month,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free lawsuit evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Lawsuits
Pradaxa, which is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation, was approved by the U.S. Food & Drug Administration (FDA) in October 2010. According to a recent article from Bloomberg.com, internal bleeding is a potential Pradaxa side effect for which there is no readily available antidote. Among other things, Bloomberg stated that the FDA had received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011.*

On December 19th, the FDA issued a Drug Safety Communication announcing a new contraindication was being added to the Pradaxa label to warn against its use in patients with mechanical heart valves. The FDA ordered Boehringer Ingelheim to add the contraindication after the RE-ALIGN trial was halted. The study ended early when it was found that Pradaxa users were more likely to experience str
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
2. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
3. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
4. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
5. Approval of Safer Alternative to Pradaxa Delayed by FDA
6. Nexium MDL Consolidated for Bone Fracture Lawsuits: AttorneyOne Informs
7. DrugRisk Announces Updated Information on Mirena Lawsuits
8. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
9. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
10. Dr. Farshchian: Subacromion Bursitis is Now being Treated with Cell Therapy
11. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Da Vinci ... in a trial in Washington State May 23, according ... clients in surgical robot lawsuits , expresses disappointment ... da Vinci lawsuits to not read a single verdict ... case (Estate of Fred E. Taylor v. Intuitive Surgical ...
(Date:5/23/2013)... , , THURSDAY, May 23 (HealthDay News) -- Glucosamine supplements ... and knee osteoarthritis may have an unexpected side effect: ... new study of older adults suggests. Glaucoma ... (IOP) or pressure inside the eye. Left untreated, glaucoma ... In the new study of 17 people, ...
(Date:5/23/2013)... -- People who eat at fast-food restaurants are consuming ... are the worst offenders, a new study found. ... by as much as 34 percent, parents of school-age ... by as much as 20 percent," study lead researcher, ... the Robert Wood Johnson Foundation, which helped fund the ...
(Date:5/23/2013)... 23, 2013)Don,t doubt it when a woman harried by ... things. A new study published online in Menopause ... (NAMS), helps confirm with objective tests that what these ... the past, some studies showed that hot flashes were ... showed that, even though there was a relationship between ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... announcement (PSA) campaign that empowers parents to talk to ... dangers of underage drinking, was launched today by the ... , The kickoff occurred in conjunction with SAMHSA’s 2013 ... awareness of, and action around, substance abuse and mental ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2
... ... ... leading,floral service offering only hand-arranged, hand-delivered floral,arrangements by local Teleflora ... To Cancer (SU2C) a new initiative to raise,philanthropic dollars for ...
... Plan Provider,s Payment ... Improves Operational Efficiency, CAMBRIDGE, England and SAN ... AU. or AU.L), a global leader in,infrastructure software ... (GVS) has selected Cardiff,s information capture and,business process ...
... students across 70 colleges and universities who completed a ... episode of suicidal thinking at some point in their ... seriously considered attempting suicide and more than 5 percent ... their lifetime. , Presenting Sunday at the 116th Annual ...
... A second Phase I AIDS vaccine clinical trial ... Medical Research, the National AIDS Control Organization and the ... trial of an MVA-based AIDS vaccine candidate (TBC-M4), which ... had acceptable levels of safety and was well tolerated. ...
... in Bad Faith, LOS ANGELES, Aug. 15 ... Daughters of Charity,Health System are planning a one-day strike ... Healthcare Workers-West have been,bargaining a new contract with the ... any economic proposals, and is attempting to,take away the ...
... Aug. 15 Following is a,statement of Betsy ... Horizon Blue Cross Blue Shield today submitted an ... insurer to a publicly traded for-profit,company., All ... of such a,conversion. With approximately 2.9 million members, ...
Cached Medicine News:Health News:Teleflora and Stand Up To Cancer Join Forces 2Health News:Teleflora and Stand Up To Cancer Join Forces 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 2Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 4Health News:Suicidal thoughts among college students more common than expected 2Health News:Suicidal thoughts among college students more common than expected 3Health News:India continues to progress in AIDS vaccine development efforts 2Health News:India continues to progress in AIDS vaccine development efforts 3Health News:NJHA Raises Questions Regarding Horizon's Proposal to Convert to For-Profit Health Insurer 2
(Date:5/23/2013)... , May 23, 2013 Isis Pharmaceuticals, Inc. ... today announced that management will present a company overview at ... Conference on Thursday, May 30, 2013 at 8:40 a.m. ET ... live audio webcast of the presentation will be available on ... www.isispharm.com .  A replay will be available on the ...
(Date:5/23/2013)... 2013  Inhibikase Therapeutics, Inc., an emerging leader ... will present new results on its antiviral program ... by the PML Consortium (composed of Pfizer, Bristol-Meyers ... is the causative agent of Progressive Multifocal Leukoencephalopathy ... an extended release formulation, can clear JC polyomavirus ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Echo ... has committed to waive down the Acceptance Threshold from ... Affected plus one Elan Share in accordance with the ... to the conditions summarized below. Under the ... to acquire Elan (NYSE: ELN ) for ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10
... , SEATTLE , Jan. ... ) today announced that Kyoto University,s Department of ... NAS for a new collaboration project focused on identifying ... IQ, the Department has unified ultrasonic tomography, retinal tomography and ...
... , PALM CITY, Fla. , Jan. 25 ... is pleased to announce its association with the commencement of ... provides for the promotion of MedFlash® through The Orlando Magic,s ... Orlando, Florida,s Walgreens stores.  In store promotional displays will ...
Cached Medicine Technology:Leading Japanese University Powers Diagnostic Imaging Research With Isilon IQ 2Leading Japanese University Powers Diagnostic Imaging Research With Isilon IQ 3Connectyx Announces MedFlash(R) 'Sixth Man Fan Promotion' in Conjunction With Walgreens and The Orlando Magic 2Connectyx Announces MedFlash(R) 'Sixth Man Fan Promotion' in Conjunction With Walgreens and The Orlando Magic 3Connectyx Announces MedFlash(R) 'Sixth Man Fan Promotion' in Conjunction With Walgreens and The Orlando Magic 4
... XL Advantage delivers higher magnification for advanced ... true image, even at the highest magnification. ... clarity and precise color rendition is ideal ... an anti-reflective coating produce a superior image. ...
... doublet objective and high power negative lens ... The true benefit of this system is ... clarity is made possible due to a ... aluminum bar and individual interpupillary adjustment provides ...
... Keeler Galilean loupes are ideal for ... increased magnification and a large field ... are laser aligned, lightweight and comfortable ... working distance and superior depth of ...
23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov...
Medicine Products: